Marlène Gallet

560 total citations
17 papers, 450 citations indexed

About

Marlène Gallet is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Marlène Gallet has authored 17 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Biomaterials. Recurrent topics in Marlène Gallet's work include Bone Metabolism and Diseases (6 papers), Bone health and treatments (4 papers) and Bone Tissue Engineering Materials (2 papers). Marlène Gallet is often cited by papers focused on Bone Metabolism and Diseases (6 papers), Bone health and treatments (4 papers) and Bone Tissue Engineering Materials (2 papers). Marlène Gallet collaborates with scholars based in France, Netherlands and Italy. Marlène Gallet's co-authors include Jean-Marc Vanacker, Saı̈d Kamel, Michel Brazier, Nicolas Sévenet, Romuald Mentaverri, Pierre Jurdic, Peggy Parroche, Jean‐Philippe Rasigade, Sophie Trouillet‐Assant and Pauline Nauroy and has published in prestigious journals such as PLoS ONE, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Marlène Gallet

17 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marlène Gallet France 12 172 85 84 81 75 17 450
Srinath Govindarajan Belgium 15 223 1.3× 58 0.7× 94 1.1× 41 0.5× 68 0.9× 24 692
Ehsan Janzamin Iran 14 201 1.2× 51 0.6× 40 0.5× 116 1.4× 24 0.3× 26 665
Eleonora Palagano Italy 13 234 1.4× 69 0.8× 125 1.5× 41 0.5× 49 0.7× 27 512
Sandra Parenti Italy 14 228 1.3× 40 0.5× 75 0.9× 44 0.5× 38 0.5× 27 430
Su Yu United States 9 222 1.3× 50 0.6× 48 0.6× 53 0.7× 20 0.3× 14 485
Yohei Hosokawa Japan 12 140 0.8× 31 0.4× 85 1.0× 78 1.0× 60 0.8× 50 485
Masahiro Nishimura Japan 12 181 1.1× 34 0.4× 45 0.5× 45 0.6× 45 0.6× 31 405
Ai Yamada Japan 14 232 1.3× 41 0.5× 94 1.1× 58 0.7× 28 0.4× 57 559
Shan-Chuan Zhao United States 8 487 2.8× 105 1.2× 101 1.2× 45 0.6× 37 0.5× 9 648
Maryam Kabir‐Salmani Iran 16 186 1.1× 41 0.5× 41 0.5× 42 0.5× 52 0.7× 31 622

Countries citing papers authored by Marlène Gallet

Since Specialization
Citations

This map shows the geographic impact of Marlène Gallet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marlène Gallet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marlène Gallet more than expected).

Fields of papers citing papers by Marlène Gallet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marlène Gallet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marlène Gallet. The network helps show where Marlène Gallet may publish in the future.

Co-authorship network of co-authors of Marlène Gallet

This figure shows the co-authorship network connecting the top 25 collaborators of Marlène Gallet. A scholar is included among the top collaborators of Marlène Gallet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marlène Gallet. Marlène Gallet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Six, Isabelle, Gaëlle Lenglet, Loı̈c Louvet, et al.. (2020). Uremic Toxins and Vascular Dysfunction. Toxins. 12(6). 404–404. 49 indexed citations
2.
Brémond‐Gignac, Dominique, Alejandra Daruich, Marlène Gallet, et al.. (2019). CENTRAL RETINAL VEIN OCCLUSION IN OTHERWISE HEALTHY CHILDREN AND ADOLESCENTS. Retina. 40(7). 1339–1343. 6 indexed citations
3.
Jedraszak, Guillaume, et al.. (2015). Azoospermia and trisomy 18p syndrome: a fortuitous association? A patient report and a review of the literature. Molecular Cytogenetics. 8(1). 34–34. 15 indexed citations
4.
Trouillet‐Assant, Sophie, Marlène Gallet, Pauline Nauroy, et al.. (2014). Dual Impact of Live Staphylococcus aureus on the Osteoclast Lineage, Leading to Increased Bone Resorption. The Journal of Infectious Diseases. 211(4). 571–581. 80 indexed citations
5.
Gallet, Marlène, Eric Haÿ, Caroline Marty, et al.. (2013). Repression of Osteoblast Maturation by ERRα Accounts for Bone Loss Induced by Estrogen Deficiency. PLoS ONE. 8(1). e54837–e54837. 23 indexed citations
6.
Gallet, Marlène & Jean-Marc Vanacker. (2010). ERR receptors as potential targets in osteoporosis. Trends in Endocrinology and Metabolism. 21(10). 637–641. 40 indexed citations
7.
Gallet, Marlène, Muriel Vayssade, Marco Morra, et al.. (2009). Inhibition of LPS-induced proinflammatory responses of J774.2 macrophages by immobilized enzymatically tailored pectins. Acta Biomaterialia. 5(7). 2618–2622. 9 indexed citations
8.
Teyssier, Catherine, Marlène Gallet, Bénédicte Rabier, et al.. (2009). Absence of ERRα in Female Mice Confers Resistance to Bone Loss Induced by Age or Estrogen-Deficiency. PLoS ONE. 4(11). e7942–e7942. 38 indexed citations
9.
Nagel, M.D., H.A. Schols, Marco Morra, et al.. (2008). Enzymatically-tailored pectins differentially influence the morphology, adhesion, cell cycle progression and survival of fibroblasts. Biochimica et Biophysica Acta (BBA) - General Subjects. 1780(7-8). 995–1003. 29 indexed citations
10.
Nagel, M.D., Pascale Vigneron, Cyrill Bussy, et al.. (2008). Modulation of fibroblast behaviour by enzymatically-tailored pectins: PectiCoat. Computer Methods in Biomechanics & Biomedical Engineering. 11(sup001). 171–172. 1 indexed citations
11.
Duplat, Denis, Anne Chabadel, Marlène Gallet, et al.. (2007). The in vitro osteoclastic degradation of nacre. Biomaterials. 28(12). 2155–2162. 43 indexed citations
12.
Duplat, Denis, Marlène Gallet, Sophie Berland, et al.. (2007). The effect of molecules in mother-of-pearl on the decrease in bone resorption through the inhibition of osteoclast cathepsin K. Biomaterials. 28(32). 4769–4778. 25 indexed citations
13.
Gallet, Marlène, et al.. (2006). Imatinib mesylate (Gleevec®) enhances mature osteoclast apoptosis and suppresses osteoclast bone resorbing activity. European Journal of Pharmacology. 551(1-3). 27–33. 55 indexed citations
14.
Gallet, Marlène, Romuald Mentaverri, Nicolas Sévenet, Michel Brazier, & Saı̈d Kamel. (2006). Ability of breast cancer cell lines to stimulate bone resorbing activity of mature osteoclasts correlates with an anti-apoptotic effect mediated by macrophage colony stimulating factor. APOPTOSIS. 11(11). 1909–1921. 16 indexed citations
15.
Gallet, Marlène, Nicolas Sévenet, Claude Dupont, Michel Brazier, & Saı̈d Kamel. (2004). Breast cancer cell line MDA-MB 231 exerts a potent and direct anti-apoptotic effect on mature osteoclasts. Biochemical and Biophysical Research Communications. 319(2). 690–696. 14 indexed citations
16.
Chevreau, Elisabeth E., et al.. (1998). INHERITANCE AND LINKAGE OF ISOZYME LOCI IN PEAR. Acta Horticulturae. 355–358. 4 indexed citations
17.
Gallet, Marlène, et al.. (1992). [A case report of Russel's diencephalic cachexia].. PubMed. 39(3). 189–93. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026